CAMBRIDGE, Mass.--(BUSINESS WIRE)--GnuBIO, Inc. (GnuBIO), www.gnubio.com a pioneer in the Desktop DNA sequencing market, announced today that it has initiated the build of its beta system. Using innovative approaches, the company has enhanced many technical capabilities found only in its droplet-based DNA sequencing system – including advances in molecular biology, real time informatics and optics - and is now assembling the beta systems in advance of full commercial launch.
